Skip to main content
Back
CLOV logo

Clover Health Investments, Corp.

Data quality: 100%
CLOV
NASDAQ Healthcare Medical - Healthcare Plans
$1.85
▼ $0.04 (-2.12%)
Mkt Cap: 947.16M
Day Range
$1.85 $1.94
52-Week Range
$1.85 $3.92
Volume
4,657,086
50D / 200D Avg
$2.19 / $2.65
Prev Close
$1.89

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -11.1 0.4
P/B 3.1 2.9
ROE % -26.3 3.7
Net Margin % -4.5 3.8
Rev Growth 5Y % 6.9 10.0
D/E 0.0 0.2

Key Takeaways

Revenue grew 6.93% annually over 5 years — modest growth
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -68.98M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 33.41%
Capital efficient — spends only 0.11% of revenue on capex

Growth

Revenue Growth (5Y)
6.93%
Revenue (1Y)40.34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-26.33%
ROIC-20.78%
Net Margin-4.45%
Op. Margin-4.44%

Safety

Debt / Equity
0.00
Current Ratio1.47
Interest Coverage0.00

Valuation

P/E Ratio
-11.07
P/B Ratio3.07
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 40.34% Revenue Growth (3Y) 23.55%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 6.93% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.92B Net Income (TTM) -85.55M
ROE -26.33% ROA -15.81%
Gross Margin 18.49% Operating Margin -4.44%
Net Margin -4.45% Free Cash Flow (TTM) -68.98M
ROIC -20.78% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 1.47
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -11.07 P/B Ratio 3.07
P/S Ratio 0.49 PEG Ratio -0.15
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 947.16M Enterprise Value 868.86M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.92B 1.37B 1.26B 1.10B 1.47B
Net Income -85.55M -43.01M -213.36M -339.57M -587.76M
EPS (Diluted) -0.17 -0.09 -0.45 -0.71 -1.25
Gross Profit 355.88M 364.80M 255.95M 103.48M -79.18M
Operating Income -85.53M -45.75M -205.33M -286.66M -636.99M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 541.01M 580.74M 570.67M 808.62M 950.80M
Total Liabilities 232.31M 239.60M 284.28M 451.73M 411.49M
Shareholders' Equity 308.70M 341.14M 286.39M 356.89M 535.41M
Total Debt 0.0 0.0 4.66M 5.86M 27.83M
Cash & Equivalents 78.30M 194.54M 116.41M 103.79M 299.97M
Current Assets 307.86M 343.12M 427.97M 625.00M 752.55M
Current Liabilities 208.82M 213.52M 261.12M 431.51M 372.62M

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#35 of 616
82

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026